Smith Group Asset Management’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q4 | – | Sell |
-8,278
| Closed | -$554K | – | 535 |
|
|
2015
Q3 | $554K | Sell |
8,278
-3
| -0% | -$201 | 0.02% | 191 |
|
|
2015
Q2 | $806K | Buy |
8,281
+2,245
| +37% | +$219K | 0.03% | 181 |
|
|
2015
Q1 | $564K | Buy |
+6,036
| New | +$564K | 0.02% | 193 |
|
|
2013
Q4 | – | Sell |
-21,001
| Closed | -$626K | – | 453 |
|
|
2013
Q3 | $626K | Buy |
21,001
+2,590
| +14% | +$77.2K | 0.03% | 186 |
|
|
2013
Q2 | $976K | Buy |
+18,411
| New | +$976K | 0.04% | 182 |
|